Cite Filings / SION / 0001628280-26-027496

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Sionna Therapeutics, Inc. Filed 2026-04-27 Acc 0001628280-26-027496

Documents 1

DEFA14A Proxy Materials , a2026sionnatherapeuticsinc.htm

Around this filing

2026-04-27 ARS Annual Report to Security Holders
2026-04-27 DEFA14A Proxy Materials
2026-04-27 DEF 14A Proxy Statement
2026-04-21 4 Director sold 55,345 shares at an average $44.67 ($2,472,343)
2026-04-21 4 Director sold 55,345 shares at an average $44.67 ($2,472,343)
2026-04-20 SCHEDULE 13D/A Beneficial Ownership Report
2025-04-29 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a2026sionnatherapeuticsinc.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…